Models of focal cerebral ischemia in the nonhuman primate

被引:79
作者
Fukuda, S [1 ]
del Zoppo, GJ [1 ]
机构
[1] Scripps Res Inst, Dept Mol & Expt Med, La Jolla, CA USA
关键词
arterial occlusion; cerebral ischerma; microvessel; neuron; nonhuman primate; stroke; transorbital outcomes;
D O I
10.1093/ilar.44.2.96
中图分类号
S85 [动物医学(兽医学)];
学科分类号
0906 ;
摘要
Ischemic stroke is a uniquely human disease syndrome. Models of focal cerebral ischemia developed in nonhuman primates provide clinically relevant platforms for investigating pathophysiological alterations associated with ischemic brain injury, microvascular responses, treatment responses, and clinically relevant outcomes that may be appropriate for ischemic stroke patients. A considerable number of advantages attend the use of nonhuman primate models in cerebral vascular research. Appropriate development of such models requires neurosurgical expertise to produce single or multiple vascular occlusions. A number of experimentally and clinically accessible outcomes can be measured, including neurological deficits, neuron injury, evidence of non-neuronal cell injury, infarction volume, real-time imaging of injury development, vascular responses, regional cerebral blood flow, microvascular events, the relation between neuron and vascular events, and behavioral outcomes. Nonhuman primate models of focal cerebral ischemia provide excellent Opportunities for understanding the vascular and cellular pathophysiology of cerebral ischemic injury, which resembles human ischemic stroke, and the appropriate study of pharmacological interventions in a human relevant setting.
引用
收藏
页码:96 / 104
页数:9
相关论文
共 83 条
[11]   Temporary Occlusion of the Middle Cerebral Artery in the Monkey: Clinical and Pathological Observations [J].
Crowell, Robert M. ;
Olsson, Yngve ;
Klatzo, Igor ;
Ommaya, Ayub .
STROKE, 1970, 1 (06) :439-448
[12]   Rat neutrophils express α4 and β1 integrins and bind to vascular cell adhesion molecule-1 (VCAM-1) and mucosal addressin cell adhesion molecule-1 (MAdCAM-1) [J].
Davenpeck, KL ;
Sterbinsky, SA ;
Bochner, BS .
BLOOD, 1998, 91 (07) :2341-2346
[13]   PROACT: A phase II randomized trial of recombinant pro-urokinase by direct arterial delivery in acute middle cerebral artery stroke [J].
del Zoppo, GJ ;
Higashida, RT ;
Furlan, AJ ;
Pessin, MS ;
Rowley, HA ;
Gent, M .
STROKE, 1998, 29 (01) :4-11
[14]   RECOMBINANT TISSUE PLASMINOGEN-ACTIVATOR IN ACUTE THROMBOTIC AND EMBOLIC STROKE [J].
DELZOPPO, GJ ;
POECK, K ;
PESSIN, MS ;
WOLPERT, SM ;
FURLAN, AJ ;
FERBERT, A ;
ALBERTS, MJ ;
ZIVIN, JA ;
WECHSLER, L ;
BUSSE, O ;
GREENLEE, R ;
BRASS, L ;
MOHR, JP ;
FELDMANN, E ;
HACKE, W ;
KASE, CS ;
BILLER, J ;
GRESS, D ;
OTIS, SM .
ANNALS OF NEUROLOGY, 1992, 32 (01) :78-86
[15]   HEMORRHAGIC TRANSFORMATION FOLLOWING TISSUE PLASMINOGEN-ACTIVATOR IN EXPERIMENTAL CEREBRAL INFARCTION [J].
DELZOPPO, GJ ;
COPELAND, BR ;
ANDERCHEK, K ;
HACKE, W ;
KOZIOL, JA .
STROKE, 1990, 21 (04) :596-601
[16]  
DELZOPPO GJ, 1992, THROMB HAEMOSTASIS, V68, P642
[17]   LOCAL INTRA-ARTERIAL FIBRINOLYTIC THERAPY IN ACUTE CAROTID TERRITORY STROKE - A PILOT-STUDY [J].
DELZOPPO, GJ ;
FERBERT, A ;
OTIS, S ;
BRUCKMANN, H ;
HACKE, W ;
ZYROFF, J ;
HARKER, LA ;
ZEUMER, H .
STROKE, 1988, 19 (03) :307-313
[18]   EXPERIMENTAL ACUTE THROMBOTIC STROKE IN BABOONS [J].
DELZOPPO, GJ ;
COPELAND, BR ;
HARKER, LA ;
WALTZ, TA ;
ZYROFF, J ;
HANSON, SR ;
BATTENBERG, E .
STROKE, 1986, 17 (06) :1254-1265
[19]   FIBRINOLYTIC AGENTS IN ANIMAL-MODELS OF CEREBROVASCULAR ISCHEMIA [J].
DELZOPPO, GJ .
FIBRINOLYSIS, 1990, 4 :3-7
[20]   POLYMORPHONUCLEAR LEUKOCYTES OCCLUDE CAPILLARIES FOLLOWING MIDDLE CEREBRAL-ARTERY OCCLUSION AND REPERFUSION IN BABOONS [J].
DELZOPPO, GJ ;
SCHMIDSCHONBEIN, GW ;
MORI, E ;
COPELAND, BR ;
CHANG, CM .
STROKE, 1991, 22 (10) :1276-1283